- Brown & Brown‘s adjusted EPS for Q2 stands at 93 cents, surpassing the previous year’s 68 cents and the estimated 88 cents.
- Organic revenue growth reached 10%, exceeding the estimate of 7.06%.
- Total revenue is $1.18 billion, marking a 12% increase year-over-year and beating the estimated $1.14 billion.
- EBITDAC margin improved to 38.3%, up from last year’s 33.9%.
- Compensation expenses rose to $585 million, a 10% increase year-over-year, and above the estimated $574.2 million.
- Analyst ratings include 6 buys, 6 holds, and 1 sell.
A look at Brown & Brown Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 2 | |
| Growth | 4 | |
| Resilience | 3 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.0 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on the Smartkarma Smart Scores, Brown & Brown shows a promising long-term outlook. The company scores high in Growth and Momentum, indicating strong potential for future expansion and positive market momentum. With a solid score in Resilience, Brown & Brown demonstrates the ability to weather economic fluctuations.
Although Value and Dividend scores are not as high, the overall positive outlook on Growth and Momentum suggests that Brown & Brown is well-positioned for future success. As a provider of insurance, reinsurance, and related services with a nationwide presence, Brown & Brown is poised to capitalize on growth opportunities in the insurance industry.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
